| Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control AE Bivona, AS Alberti, N Cerny, SN Trinitario, EL Malchiodi Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (5), 165658, 2020 | 64 | 2020 |
| Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection A Sanchez Alberti, AE Bivona, N Cerny, K Schulze, S Weißmann, ... NPJ vaccines 2 (1), 9, 2017 | 58 | 2017 |
| Oral Multicomponent DNA Vaccine Delivered by Attenuated Salmonella Elicited Immunoprotection Against American Trypanosomiasis SI Cazorla, MN Matos, N Cerny, C Ramirez, AS Alberti, AE Bivona, ... The Journal of Infectious Diseases 211 (5), 698-707, 2015 | 41 | 2015 |
| Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine AE Bivona, A Sánchez Alberti, MN Matos, N Cerny, AC Cardoso, ... PLoS Neglected Tropical Diseases 12 (3), e0006384, 2018 | 40 | 2018 |
| Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp. LC Laurella, N Cerny, AE Bivona, A Sanchez Alberti, G Giberti, ... PLoS Neglected Tropical Diseases 11 (9), e0005929, 2017 | 35 | 2017 |
| Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi A Sanchez Alberti, AE Bivona, MN Matos, N Cerny, K Schulze, ... Frontiers in Immunology 11, 128, 2020 | 25 | 2020 |
| Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection N Cerny, A Sanchez Alberti, AE Bivona, MC De Marzi, FM Frank, ... Human vaccines & immunotherapeutics 12 (2), 438-450, 2016 | 25 | 2016 |
| A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection MN Matos, AS Alberti, C Morales, SI Cazorla, EL Malchiodi Vaccine 34 (28), 3243-3251, 2016 | 23 | 2016 |
| Trypanocidal activity of four sesquiterpene lactones isolated from Asteraceae species OG Elso, AE Bivona, A Sanchez Alberti, N Cerny, L Fabian, C Morales, ... Molecules 25 (9), 2014, 2020 | 22 | 2020 |
| Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis VP Sülsen, EF Lizarraga, OG Elso, N Cerny, A Sanchez Alberti, ... Molecules 24 (7), 1209, 2019 | 19 | 2019 |
| Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi N Cerny, AE Bivona, A Sanchez Alberti, SN Trinitario, C Morales, ... Frontiers in immunology 11, 565142, 2020 | 17 | 2020 |
| Preparation of sesquiterpene lactone derivatives: Cytotoxic activity and selectivity of action MF Beer, AE Bivona, A Sánchez Alberti, N Cerny, GF Reta, VS Martín, ... Molecules 24 (6), 1113, 2019 | 13 | 2019 |
| Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens AE Bivona, N Cerny, AS Alberti, SI Cazorla, EL Malchiodi Vaccine Design: Methods and Protocols, Volume 2: Vaccines for Veterinary …, 2016 | 8 | 2016 |
| Heterologous chimeric construct comprising a modified bacterial superantigen and a cruzipain domain confers protection against Trypanosoma cruzi infection MB Antonoglou, A Sánchez Alberti, DM Redolfi, AE Bivona, ... Frontiers in Immunology 11, 547865, 2020 | 7 | 2020 |
| Antitrypanosomal and antileishmanial activities AS Alberti, N Cerny, A Bivona, SI Cazorla Sesquiterpene Lactones: Advances in their Chemistry and Biological Aspects …, 2018 | 7 | 2018 |
| In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection AS Alberti, MF Beer, N Cerny, AE Bivona, L Fabian, C Morales, A Moglioni, ... ACS omega 7 (1), 968, 2022 | 4 | 2022 |
| In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection A Sanchez Alberti, MF Beer, N Cerny, AE Bivona, L Fabian, C Morales, ... ACS Omega 7 (1), 968-978, 2021 | 4 | 2021 |
| Recombinant cysteine proteinase B from Leishmania braziliensis and its domains: promising antigens for serodiagnosis of cutaneous and visceral leishmaniasis in dogs AE Bivona, L Czentner, A Sanchez Alberti, N Cerny, ... Journal of Clinical Microbiology 57 (11), 10.1128/jcm. 00819-19, 2019 | 4 | 2019 |
| Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti-Trypanosoma cruzi Activity MF Beer, GF Reta, A Puerta, AE Bivona, AS Alberti, N Cerny, ... Molecules 27 (10), 3067, 2022 | 2 | 2022 |
| Zika virus NS4B protein targets TANK-binding kinase 1 and inhibits type I interferon production MB Sarratea, AS Alberti, DM Redolfi, SN Truant, LVI Lopez, AE Bivona, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1867 (12), 130483, 2023 | 1 | 2023 |
